Name:
Zirconium atomic absorption standard solution 1 mg/ml Zr in 5% HF
Synonym:
None
CAS:
7440-67-7
Section 1 - Chemical Product
MSDS Name:Zirconium atomic absorption standard solution 1 mg/ml Zr in 5% HF
Synonym:None
Synonym:None
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 7440-67-7 | Zirconium | <1.0 | 231-176-9 |
| Hazard Symbols: T+ C Risk Phrases: 26/27/28 35 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Very toxic by inhalation, in contact with skin and if swallowed.
Causes severe burns.Corrosive.Toxic.
Potential Health Effects
Eye:
Contact with liquid or vapor causes severe burns and possible irreversible eye damage. Contact with eyes may cause severe irritation, and possible eye burns.
Skin:
May be fatal if absorbed through the skin. Causes severe burns with delayed tissue destruction. May cause severe irritation and possible burns. Substance is rapidly absorbed through the skin. Penetration may continue for several days. Causes severe tissue necrosis and bone destruction.
Ingestion:
Causes severe digestive tract burns with abdominal pain, vomiting, and possible death. May cause systemic toxic effects on the heart, liver, and kidneys. Ingestion of large amounts of fluoride may cause salivation, nausea, vomiting, abdominal pain, fever, labored breathing. Inorganic fluorides can be harmful. Acute exposure to fluorine compounds can lead to digestive tract burns, and abdominal pain. Exposure to fluoride compounds can result in systemic toxic effects on the heart, liver, and kidneys. It may also deplete calcium levels in the body leading to hypocalcemia and death.
Contains fluoride. Human fatalities have been reported from acute poisoning. Fluoride can reduce calcium levels leading to fatal hypocalcemia.
Inhalation:
Harmful if inhaled. May cause severe irritation of the respiratory tract with sore throat, coughing, shortness of breath and delayed lung edema. May cause severe irritation of the upper respiratory tract with pain, burns, and inflammation. Causes chemical burns to the respiratory tract. May cause pulmonary edema and severe respiratory disturbances. Depletes calcium levels in the body which can lead to hypocalcemia and death.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride poisoning (fluorosis) characterized by weight loss, weakness, anemia, brittle bones, and stiff joints. Repeated inhalation may cause chronic bronchitis. Prolonged or repeated exposure may cause permanent bone structure abnormalities. Chronic exposure to fluoride compounds may cause systemic toxicity.
Very toxic by inhalation, in contact with skin and if swallowed.
Causes severe burns.Corrosive.Toxic.
Potential Health Effects
Eye:
Contact with liquid or vapor causes severe burns and possible irreversible eye damage. Contact with eyes may cause severe irritation, and possible eye burns.
Skin:
May be fatal if absorbed through the skin. Causes severe burns with delayed tissue destruction. May cause severe irritation and possible burns. Substance is rapidly absorbed through the skin. Penetration may continue for several days. Causes severe tissue necrosis and bone destruction.
Ingestion:
Causes severe digestive tract burns with abdominal pain, vomiting, and possible death. May cause systemic toxic effects on the heart, liver, and kidneys. Ingestion of large amounts of fluoride may cause salivation, nausea, vomiting, abdominal pain, fever, labored breathing. Inorganic fluorides can be harmful. Acute exposure to fluorine compounds can lead to digestive tract burns, and abdominal pain. Exposure to fluoride compounds can result in systemic toxic effects on the heart, liver, and kidneys. It may also deplete calcium levels in the body leading to hypocalcemia and death.
Contains fluoride. Human fatalities have been reported from acute poisoning. Fluoride can reduce calcium levels leading to fatal hypocalcemia.
Inhalation:
Harmful if inhaled. May cause severe irritation of the respiratory tract with sore throat, coughing, shortness of breath and delayed lung edema. May cause severe irritation of the upper respiratory tract with pain, burns, and inflammation. Causes chemical burns to the respiratory tract. May cause pulmonary edema and severe respiratory disturbances. Depletes calcium levels in the body which can lead to hypocalcemia and death.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride poisoning (fluorosis) characterized by weight loss, weakness, anemia, brittle bones, and stiff joints. Repeated inhalation may cause chronic bronchitis. Prolonged or repeated exposure may cause permanent bone structure abnormalities. Chronic exposure to fluoride compounds may cause systemic toxicity.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed. Eye exposure may be treated by irrigation with 1% calcium gluconate drops after immediate and copious irrigation with water for at least 30 minutes. Spills of HF should be flushed until medical attention arrives. SPEEDY ACTION IS CRITICAL! GET MEDICAL ATTENTION IMMEDIATELY! Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Discard contaminated clothing in a manner which limits further exposure. Destroy contaminated shoes. For exposures to hydrofluoric acid concentrations less than 20%, liberal and frequent applications of a 2.5% calcium gluoconate gel may be applied. Spills of HF should be flushed until medical attention arrives. SPEEDY ACTION IS CRITICAL! GET MEDICAL ATTENTION IMMEDIATELY.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately. SPEED IS ESSENTIAL.
A DOCTOR MUST BE NOTIFIED AT ONCE. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. SPEED IS ESSENTIAL, OBTAIN MEDICAL AID IMMEDIATELY.
Notes to Physician:
Due to delayed and persistent symptoms, observe patient closely for 48 hours. Prompt action is essential in all cases of contact.
Antidote: The use of calcium gluconate to precipitate the oxalate should be determined by only qualified medical personnel. Always have calcium gluconate gel on hand. The use of infilitration therapy and intraarterial therapy for hydrofluoric acid burns resulting from concentrations greater than 20% should be made by qualified medical personnel.
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Discard contaminated clothing in a manner which limits further exposure. Destroy contaminated shoes. For exposures to hydrofluoric acid concentrations less than 20%, liberal and frequent applications of a 2.5% calcium gluoconate gel may be applied. Spills of HF should be flushed until medical attention arrives. SPEEDY ACTION IS CRITICAL! GET MEDICAL ATTENTION IMMEDIATELY.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately. SPEED IS ESSENTIAL.
A DOCTOR MUST BE NOTIFIED AT ONCE. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. SPEED IS ESSENTIAL, OBTAIN MEDICAL AID IMMEDIATELY.
Notes to Physician:
Due to delayed and persistent symptoms, observe patient closely for 48 hours. Prompt action is essential in all cases of contact.
Antidote: The use of calcium gluconate to precipitate the oxalate should be determined by only qualified medical personnel. Always have calcium gluconate gel on hand. The use of infilitration therapy and intraarterial therapy for hydrofluoric acid burns resulting from concentrations greater than 20% should be made by qualified medical personnel.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Reacts with most metals to form highly flammable hydrogen gas which can form explosive mixtures with air. Containers may explode in the heat of a fire. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Contact with metals may evolve flammable hydrogen gas. Non-combustible, substance itself does not burn but may decompose upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Substance is nonflammable; use agent most appropriate to extinguish surrounding fire. Do NOT get water inside containers. For large fires, use water spray, fog or alcohol-resistant foam. Do NOT use straight streams of water. For small fires, use carbon dioxide, dry chemical, dry sand, or alcohol-resistant foam.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Reacts with most metals to form highly flammable hydrogen gas which can form explosive mixtures with air. Containers may explode in the heat of a fire. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Contact with metals may evolve flammable hydrogen gas. Non-combustible, substance itself does not burn but may decompose upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Substance is nonflammable; use agent most appropriate to extinguish surrounding fire. Do NOT get water inside containers. For large fires, use water spray, fog or alcohol-resistant foam. Do NOT use straight streams of water. For small fires, use carbon dioxide, dry chemical, dry sand, or alcohol-resistant foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Wear a self contained breathing apparatus and appropriate personal protection. (See Exposure Controls, Personal Protection section).
Neutralize spill with sodium bicarbonate. Use water spray to disperse the gas/vapor. Remove all sources of ignition. Absorb spill using an absorbent, non-combustible material such as earth, sand, or vermiculite. Do not use combustible materials such as sawdust.
Provide ventilation.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Wear a self contained breathing apparatus and appropriate personal protection. (See Exposure Controls, Personal Protection section).
Neutralize spill with sodium bicarbonate. Use water spray to disperse the gas/vapor. Remove all sources of ignition. Absorb spill using an absorbent, non-combustible material such as earth, sand, or vermiculite. Do not use combustible materials such as sawdust.
Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not allow contact with water. Discard contaminated shoes. Use caution when opening.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area. Do not store in metal or glass containers.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not allow contact with water. Discard contaminated shoes. Use caution when opening.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area. Do not store in metal or glass containers.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 7440-67-7: United States OSHA: 5 mg/m3 TWA Belgium - TWA: 5 mg/m3 VLE Belgium - STEL: 10 mg/m3 VLE Germany: 1 mg/m3 TWA (inhalable fraction) Malaysia: 5 mg/m3 TWA Netherlands: 5 mg/m3 MAC Russia: 6 mg/m3 TWA Spain: 5 mg/m3 VLA-ED Spain: 10 mg/m3 VLA-EC CAS# 7664-39-3: United Kingdom, WEL - TWA: 1.8 ppm TWA (as F); 1.5 mg/m3 TWA (as United Kingdom, WEL - STEL: 3 ppm STEL (as F); 2.5 mg/m3 STEL (as United States OSHA: 3 ppm TWA Belgium - TWA: 1.8 ppm VLE; 1.5 mg/m3 VLE Belgium - STEL: 3 ppm VLE; 2.5 mg/m3 VLE France - VLE: 3 ppm VLE; 2.5 mg/m3 VLE Germany: 3 ppm TWA; 2.5 mg/m3 TWA Germany: Skin absorber Japan: 3 ppm Ceiling; 2.5 mg/m3 Ceiling Malaysia: 3 ppm Ceiling (as F); 2.3 mg/m3 Ceiling (as F) Netherlands: 3.3 ppm STEL; 2.5 mg/m3 STEL (as F) Russia: 0.5 mg/m3 TWA Russia: 0.1 mg/m3 STEL Spain: 1.8 ppm VLA-ED; 1.5 mg/m3 VLA-ED Spain: 3 ppm VLA-EC; 2.5 mg/m3 VLA-EC CAS# 7732-18-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear a chemical apron. Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 7440-67-7: United States OSHA: 5 mg/m3 TWA Belgium - TWA: 5 mg/m3 VLE Belgium - STEL: 10 mg/m3 VLE Germany: 1 mg/m3 TWA (inhalable fraction) Malaysia: 5 mg/m3 TWA Netherlands: 5 mg/m3 MAC Russia: 6 mg/m3 TWA Spain: 5 mg/m3 VLA-ED Spain: 10 mg/m3 VLA-EC CAS# 7664-39-3: United Kingdom, WEL - TWA: 1.8 ppm TWA (as F); 1.5 mg/m3 TWA (as United Kingdom, WEL - STEL: 3 ppm STEL (as F); 2.5 mg/m3 STEL (as United States OSHA: 3 ppm TWA Belgium - TWA: 1.8 ppm VLE; 1.5 mg/m3 VLE Belgium - STEL: 3 ppm VLE; 2.5 mg/m3 VLE France - VLE: 3 ppm VLE; 2.5 mg/m3 VLE Germany: 3 ppm TWA; 2.5 mg/m3 TWA Germany: Skin absorber Japan: 3 ppm Ceiling; 2.5 mg/m3 Ceiling Malaysia: 3 ppm Ceiling (as F); 2.3 mg/m3 Ceiling (as F) Netherlands: 3.3 ppm STEL; 2.5 mg/m3 STEL (as F) Russia: 0.5 mg/m3 TWA Russia: 0.1 mg/m3 STEL Spain: 1.8 ppm VLA-ED; 1.5 mg/m3 VLA-ED Spain: 3 ppm VLA-EC; 2.5 mg/m3 VLA-EC CAS# 7732-18-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear a chemical apron. Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Liquid
Color: not available
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: miscible
Specific Gravity/Density:
Molecular Formula: Solution
Molecular Weight: 0
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, metals, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Substance is incompatible with over 35 specific chemicals. Please refer to the NFPA Fire Protection Guide for specifics.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen fluoride gas, fluoride fumes.
Hazardous Polymerization: Has not been reported.
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, metals, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Substance is incompatible with over 35 specific chemicals. Please refer to the NFPA Fire Protection Guide for specifics.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen fluoride gas, fluoride fumes.
Hazardous Polymerization: Has not been reported.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7440-67-7: ZH7070000 CAS# 7664-39-3: MW7875000 CAS# 7732-18-5: ZC0110000 LD50/LC50:
Not available.
CAS# 7664-39-3: Inhalation, mouse: LC50 = 342 ppm/1H; Inhalation, mouse: LC50 = 5000 mg/m3/5M; Inhalation, mouse: LC50 = 270 mg/m3/60M; Inhalation, rat: LC50 = 1276 ppm/1H; Inhalation, rat: LC50 = 1100 mg/m3/60M.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Zirconium - Not listed by ACGIH, IARC, or NTP.
Hydrofluoric acid - Not listed by ACGIH, IARC, or NTP.
Water - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
CAS# 7440-67-7: ZH7070000 CAS# 7664-39-3: MW7875000 CAS# 7732-18-5: ZC0110000 LD50/LC50:
Not available.
CAS# 7664-39-3: Inhalation, mouse: LC50 = 342 ppm/1H; Inhalation, mouse: LC50 = 5000 mg/m3/5M; Inhalation, mouse: LC50 = 270 mg/m3/60M; Inhalation, rat: LC50 = 1276 ppm/1H; Inhalation, rat: LC50 = 1100 mg/m3/60M.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Zirconium - Not listed by ACGIH, IARC, or NTP.
Hydrofluoric acid - Not listed by ACGIH, IARC, or NTP.
Water - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Fish (fresh water) 60 ppm lethal (time period not specified).
Fish (fresh water) 60 ppm lethal (time period not specified).
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: HYDROFLUORIC ACID
Hazard Class: 8 (6.1)
UN Number: 1790
Packing Group: II
IMO
Shipping Name: HYDROFLUORIC ACID
Hazard Class: 8 (6.1)
UN Number: 1790
Packing Group: II
RID/ADR
Shipping Name: HYDROFLUORIC ACID SOLUTION
Hazard Class: 8
UN Number: 1790
Packing group: II
USA RQ: CAS# 7664-39-3: 100 lb final RQ; 45.4 kg final RQ
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+ C
Risk Phrases:
R 26/27/28 Very toxic by inhalation, in contact with
skin and if swallowed.
R 35 Causes severe burns.
Safety Phrases:
S 7/9 Keep container tightly closed and in a
well-ventilated place.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7440-67-7: No information available.
CAS# 7664-39-3: 1
CAS# 7732-18-5: No information available.
Canada
CAS# 7440-67-7 is listed on Canadas DSL List.
CAS# 7664-39-3 is listed on Canadas DSL List.
CAS# 7732-18-5 is listed on Canadas DSL List.
CAS# 7440-67-7 is listed on Canadas Ingredient Disclosure List.
CAS# 7664-39-3 is listed on Canadas Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7440-67-7 is listed on the TSCA inventory.
CAS# 7664-39-3 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
